EHTH

eHealth, Inc.

6 filings tracked

healthcareinsurance brokerageSMALL ($300M-2B)

Signal Magnitude Chart

bullish

bearish

neutral

Signal Timeline

bearishMay 7

Total revenue declined 22% year-over-year to $88.0 million.

earnings miss

70%

bullishMay 7

Reduced total acquisition cost per MA-equivalent member by 10%.

margin expansion

40%

neutralMay 7

Entered into a new $125 million asset-based revolving credit facility.

debt restructure

50%

bearishMay 7

Facing a qui tam action under the Federal False Claims Act.

regulatory action

80%

bearishMay 7

Total revenue declined 22% year-over-year to $88.0 million.

earnings miss

70%

bullishMay 7

Reduced total acquisition cost per MA-equivalent member by 10%.

margin expansion

40%

neutralMay 7

Entered into a new $125 million asset-based revolving credit facility.

debt restructure

50%

bearishMay 7

Facing a qui tam action under the Federal False Claims Act.

regulatory action

80%

bearishMay 7

Total revenue declined 22% year-over-year to $88.0 million.

earnings miss

70%

bullishMay 7

Reduced total acquisition cost per MA-equivalent member by 10%.

margin expansion

40%

neutralMay 7

Entered into a new $125 million asset-based revolving credit facility.

debt restructure

50%

bearishMay 7

Facing a qui tam action under the Federal False Claims Act.

regulatory action

80%

bearishMay 7

Total revenue declined 22% year-over-year to $88.0 million.

earnings miss

70%

bullishMay 7

Reduced total acquisition cost per MA-equivalent member by 10%.

margin expansion

40%

neutralMay 7

Entered into a new $125 million asset-based revolving credit facility.

debt restructure

50%

bearishMay 7

Facing a qui tam action under the Federal False Claims Act.

regulatory action

80%

bearishMay 7

Total revenue declined 22% year-over-year to $88.0 million.

earnings miss

70%

bullishMay 7

Reduced total acquisition cost per MA-equivalent member by 10%.

margin expansion

40%

neutralMay 7

Entered into a new $125 million asset-based revolving credit facility.

debt restructure

50%

bearishMay 7

Facing a qui tam action under the Federal False Claims Act.

regulatory action

80%

bearishMay 7

Total revenue declined 22% year-over-year to $88.0 million.

earnings miss

70%

bullishMay 7

Reduced total acquisition cost per MA-equivalent member by 10%.

margin expansion

40%

neutralMay 7

Entered into a new $125 million asset-based revolving credit facility.

debt restructure

50%

bearishMay 7

Facing a qui tam action under the Federal False Claims Act.

regulatory action

80%

Filing History

10-QMay 7, 2026

The Q1 2026 filing presents a stark contrast between operational discipline and fundamental business erosion. On one hand, management has successfully slashed marketing costs and improved unit economics, generating $35.8 million in operating cash flow despite a net loss. On the other hand, the 21% decline in approved members suggests that the 'strategic pivot' may be masking a loss of market share and a struggle to maintain growth in a volatile regulatory environment. Investors are now faced with a binary outcome: either the lifetime advisory model successfully transforms eHealth into a high-LTV recurring revenue business, or the company continues to shrink until its debt and preferred stock obligations become unsustainable. The resolution of the False Claims Act litigation and the company's ability to maintain its critical carrier relationships will be the primary determinants of its long-term viability.